供肝保存液的演变和革新

喻国涛; 尹燕锋; 颜春涛; 邹光旭; 张黄燕; 马丽; 胡宗强

doi:10.3969/j.issn.1674-7445.2023165

供肝保存液的演变和革新

doi: 10.3969/j.issn.1674-7445.2023165

650011　昆明，昆明市第一人民医院肝胆胰外科

基金项目: 国家自然科学基金（82060436）；云南省科学技术厅中青年学术和技术带头人后备人才项目（202205AC160089）；云南省科学技术厅重大科技专项项目（202302AA310018）；昆明医科大学研究生创新基金（2023S397）

详细信息

作者简介:

通讯作者:
胡宗强（ORCID 0000-0002-7927-7007），博士，主任医师，研究方向为肝病基础研究与临床应用，Email：2509484088@qq.com

中图分类号: R617, R575
计量
- 文章访问数: 249
- HTML全文浏览量: 184
- PDF下载量: 29
- 被引次数: 0
出版历程
- 收稿日期: 2023-08-25
- 录用日期: 2023-11-22
- 网络出版日期: 2023-11-29
- 刊出日期: 2024-01-11

Evolution and innovation of preservation fluid for donor liver

Department of Hepatobiliary Pancreatic Surgery, the First People’s Hospital of Kunming, Kunming 650011, China

More Information

Corresponding author: Hu Zongqiang, Email: 2509484088@qq.com

摘要

摘要: 器官保存液能够改善移植物冷缺血损伤和维持移植物良好的功能。目前，如何减少供肝在冷缺血期间引起的一系列损伤，改善和提高移植物的保存质量，是目前该领域研究的热点和难点。现阶段，临床上的保存液仍未达到理想的保存效果，尤其是对于边缘供器官的保护作用不尽如人意。在当今供者极度匮乏的情况下，为了改善移植物免受冷缺血损伤，其关键要素仍然是寻求最佳的供肝保存方案。本文总结了供肝在冷缺血期间的损伤机制，保存液的分类及供肝保存液的演变历程，探讨了供肝保存液的发展方向及面临的困境，为供肝保存液的研发提供新思路和参考。
- 肝移植 /
- 供肝 /
- 保存液 /
- 冷缺血损伤 /
- 扩大标准供者 /
- 边缘供肝 /
- 氧化应激 /
- 缺血-再灌注损伤
Abstract: Organ preservation fluid could mitigate cold ischemia injury and maintain normal function of the grafts. At present, how to reduce a series of injury caused by cold ischemia of donor liver and improve the preservation quality of grafts are the hot and challenging spots in this field. Currently, preservation fluid in clinical practice has not achieved ideal preservation effect, especially for the protection of marginal donor organs. In the context of severe donor shortage, the key solution is still to explore the optimal preservation protocol for donor liver to prevent grafts from cold ischemia injury. In this article, the mechanism of donor liver injury during cold ischemia, the classification and evolution of donor liver preservation fluid were summarized, the development direction and challenges of donor liver preservation fluid were discussed, aiming to provide novel ideas and references for the research and development of donor liver preservation fluid.
- Liver transplantation /
- Donor liver /
- Preservation fluid /
- Cold ischemia injury /
- Expanded criteria donor /
- Marginal donor liver /
- Oxidative stress /
- Ischemia-reperfusion injury

HTML全文

下载: 全尺寸图片幻灯片

参考文献(39)

[1]	LING S, JIANG G, QUE Q, et al. Liver transplantation in patients with liver failure: twenty years of experience from China[J]. Liver Int, 2022, 42(9): 2110-2116. DOI: 10.1111/liv.15288.
[2]	中国肝移植注册中心, 国家肝脏移植质控中心, 国家人体捐献器官获取质控中心, 等. 中国移植器官保护专家共识(2022版)[J]. 中华消化外科杂志, 2022, 21(2): 169-184. DOI: 10.3760/cma.j.cn115610-20220214-00078. China Liver Transplant Registry, National Center for Healthcare Quality Management in Liver Transplant, National Quality Control Center for Donated Organ Procurement, et al. Chinese expert consensus on organ protection of transplantation (2022 edition)[J]. Chin J Dig Surg, 2022, 21(2): 169-184. DOI: 10.3760/cma.j.cn115610-20220214-00078.
[3]	谢炎, 蒋文涛. 供肝保存与功能维护助力肝移植发展[J]. 器官移植, 2023, 14(2): 201-206. DOI: 10.3969/j.issn.1674-7445.2023.02.004. XIE Y, JIANG WT. Liver graft preservation and functional maintenance accelerate the development of liver transplantation[J]. Organ Transplant, 2023, 14(2): 201-206. DOI: 10.3969/j.issn.1674-7445.2023.02.004.
[4]	LI J, ZHA X, KANG Y, et al. Oxygen-carrying sequential preservation mitigates liver grafts ischemia-reperfusion injury[J]. iScience, 2022, 26(1): 105858. DOI: 10.1016/j.isci.2022.105858.
[5]	DA SILVA RT, BARDALLO RG, FOLCH-PUY E, et al. IGL-2 as a unique solution for cold static preservation and machine perfusion in liver and mitochondrial protection[J]. Transplant Proc, 2022, 54(1): 73-76. DOI: 10.1016/j.transproceed.2021.10.008.
[6]	BARDALLO RG, COMPANY-MARIN I, FOLCH-PUY E, et al. PEG35 and glutathione improve mitochondrial function and reduce oxidative stress in cold fatty liver graft preservation[J]. Antioxidants (Basel), 2022, 11(1): 158. DOI: 10.3390/antiox11010158.
[7]	PRADAT P, PANTEL S, MAYNARD M, et al. End-ischemic hypothermic oxygenated perfusion for extended criteria donors in liver transplantation: a multicenter, randomized controlled trial-HOPExt[J]. Trials, 2023, 24(1): 379. DOI: 10.1186/s13063-023-07402-0.
[8]	HIRAO H, NAKAMURA K, KUPIEC-WEGLINSKI JW. Liver ischaemia-reperfusion injury: a new understanding of the role of innate immunity[J]. Nat Rev Gastroenterol Hepatol, 2022, 19(4): 239-256. DOI: 10.1038/s41575-021-00549-8.
[9]	DE BEULE J, FIEUWS S, MONBALIU D, et al. The effect of IGL-1 preservation solution on outcome after kidney transplantation: a retrospective single-center analysis[J]. Am J Transplant, 2021, 21(2): 830-837. DOI: 10.1111/ajt.16302.
[10]	YANG H, WANG Q, ZHANG P, et al. Preliminary mechanism of inhibitor of SGLT2 in fatty liver cold ischemia injury[J]. Biochem Biophys Res Commun, 2023, 646: 96-102. DOI: 10.1016/j.bbrc.2022.12.055.
[11]	BRÜGGENWIRTH IMA, VAN DER PLAS WS, VAN LEEUWEN OB, et al. Oxygenated versus non-oxygenated flush out and storage of donor livers: an experimental study[J]. Artif Organs, 2022, 46(2): 201-209. DOI: 10.1111/aor.14135.
[12]	游可为, 刘嘉馨, 王文刚,等. 含戊二醛聚合牛源HBOC的新型器官保存液对延长大鼠离体心脏保存时间的研究[J]. 中国生物医学工程学报, 2023, 42(2): 252-256. DOI: 10.3969/j.issn.0258-8021.2023.02.014. YOU KW, LIU JX, WANG WG, et al. Preservation duration of ex-vivo rat heart using a novel organ preservation solution containing glutaradehyde polymerized bovine hemoglobin[J]. Chin J Biomed Eng, 2023, 42(2): 252-256. DOI: 10.3969/j.issn.0258-8021.2023.02.014.
[13]	HINDSON J. Supercooling human livers for transplantation[J]. Nat Rev Gastroenterol Hepatol, 2019, 16(11): 647. DOI: 10.1038/s41575-019-0215-x.
[14]	KIYOSHI TAKANO DE SAIDNEUY AE, BRUNO DE REZENDE M, ROGERIO DE OLIVEIRA SALVALAGGIO P. A direct comparison between Institut Georges Lopez 1 and histidine-tryptophan-ketoglutarate preservation solutions in liver transplantation[J]. Transplant Proc, 2020, 52(5): 1262-1264. DOI: 10.1016/j.transproceed.2020.01.172.
[15]	PUEYO-PÉRIZ EM, CEPEDA C, SÁNCHEZ B, et al. Liver transplantation: analysis of preservation solutions in the andalusian registry[J]. Transplant Proc, 2022, 54(1): 15-17. DOI: 10.1016/j.transproceed.2021.10.010.
[16]	SUTHERASAN M, UTHAITHAMMARAT T, TAESOMBAT W, et al. Combination of Euro-Collins and University of Wisconsin solution: an effective and economic substitute for organ procurement[J]. Transplant Proc, 2020, 52(1): 50-53. DOI: 10.1016/j.transproceed.2019.03.069.
[17]	ALBADRANI M. Histidine-tryptophan-ketoglutarate solution versus multidose cardioplegia for myocardial protection in cardiac surgeries: a systematic review and meta-analysis[J]. J Cardiothorac Surg, 2022, 17(1): 133. DOI: 10.1186/s13019-022-01891-x.
[18]	COTTER TG, ODENWALD MA, PEREZ-GUTIERREZ A, et al. Preservation solutions for static cold storage in donation after circulatory death and donation after brain death liver transplantation in the United States[J]. Liver Transpl, 2022, 28(9): 1454-1462. DOI: 10.1002/lt.26457.
[19]	XU X, ZHU YF, LV T, et al. Histidine-tryptophan-ketoglutarate solution versus University of Wisconsin solution in adult-to-adult living donor liver transplantation: a propensity score matching analysis from mainland China[J]. Medicine (Baltimore), 2020, 99(51): e23584. DOI: 10.1097/MD.0000000000023584.
[20]	VAN DEN EYNDE J, ACHTERGAELE J, FIEUWS S, et al. The effect of organ preservation solutions on short-term outcomes after liver transplantation: a single-center retrospective study[J]. Transpl Int, 2021, 34(2): 327-338. DOI: 10.1111/tri.13799.
[21]	BARDALLO RG, DA SILVA RT, CARBONELL T, et al. Liver graft hypothermic static and oxygenated perfusion (HOPE) strategies: a mitochondrial crossroads[J]. Int J Mol Sci, 2022, 23(10): 5742. DOI: 10.3390/ijms23105742.
[22]	FUKAI M, SAKAMOTO S, SHIBATA K, et al. Combination of cold storage in a heavy water-containing solution and post-reperfusion hydrogen gas treatment reduces ischemia-reperfusion injury in rat livers[J]. Transplant Proc, 2023, 55(4): 1027-1031. DOI: 10.1016/j.transproceed.2023.03.061.
[23]	MOHR A, BROCKMANN JG, BECKER F. HTK-N: modified histidine-tryptophan-ketoglutarate solution-a promising new tool in solid organ preservation[J]. Int J Mol Sci, 2020, 21(18): 6468. DOI: 10.3390/ijms21186468.
[24]	CHAABANI R, BEJAOUI M, ZAOUALI MA, et al. Protective effects of diclofenac on liver graft preservation[J]. Can J Physiol Pharmacol, 2023, 101(8): 382-392. DOI: 10.1139/cjpp-2022-0446.
[25]	周智华, 崔心刚, 韩秋成, 等. 上海多器官保存液保存离体大鼠肝脏的实验研究[J]. 第二军医大学学报, 2007, 28(2): 122-126. DOI: 10.16781/j.0258-879X.2007.02.002. ZHOU ZH, CUI XG, HAN QC, et al. Shanghai-mutil-organ solution in preservation of rat liver: an experimental study[J]. Acad J Naval Med Univ, 2007, 28(2): 122-126. DOI: 10.16781/j.0258-879X.2007.02.002.
[26]	UTO K, SAKAMOTO S, QUE W, et al. Hydrogen-rich solution attenuates cold ischemia-reperfusion injury in rat liver transplantation[J]. BMC Gastroenterol, 2019, 19(1): 25. DOI: 10.1186/s12876-019-0939-7.
[27]	CHAI YC, DANG GX, HE HQ, et al. Hypothermic machine perfusion with metformin-University of Wisconsin solution for ex vivo preservation of standard and marginal liver grafts in a rat model[J]. World J Gastroenterol, 2017, 23(40): 7221-7231. DOI: 10.3748/wjg.v23.i40.7221.
[28]	HORVÁTH T, SÁNDOR L, BARÁTH B, et al. Methane admixture protects liver mitochondria and improves graft function after static cold storage and reperfusion[J]. Antioxidants (Basel), 2023, 12(2): 271. DOI: 10.3390/antiox12020271.
[29]	WU J, LIU X, WANG M, et al. Reduction of cold ischemic injury with the addition of compound glycyrrhizin in HTK solution in a mouse heart transplantation model[J]. Int Heart J, 2020, 61(3): 595-600. DOI: 10.1536/ihj.19-321.
[30]	SLIM C, ZAOUALI MA, NASSRALLAH H, et al. Protective potential effects of fucoidan in hepatic cold ischemia-rerfusion injury in rats[J]. Int J Biol Macromol, 2020, 155: 498-507. DOI: 10.1016/j.ijbiomac.2020.03.245.
[31]	PANTAZI E, ZAOUALI MA, BEJAOUI M, et al. Sirtuin 1 in rat orthotopic liver transplantation: an IGL-1 preservation solution approach[J]. World J Gastroenterol, 2015, 21(6): 1765-1774. DOI: 10.3748/wjg.v21.i6.1765.
[32]	WANG J, ZENG L, ZHANG Y, et al. Pharmacological properties, molecular mechanisms and therapeutic potential of ginsenoside Rg3 as an antioxidant and anti-inflammatory agent[J]. Front Pharmacol, 2022, 13: 975784. DOI: 10.3389/fphar.2022.975784.
[33]	MA W, TANG S, XIE D, et al. The protective effect of traditional Chinese medicine on liver ischemia-reperfusion injury[J]. Evid Based Complement Alternat Med, 2021: 5564401. DOI: 10.1155/2021/5564401.
[34]	MASIOR Ł, GRĄT M. Primary nonfunction and early allograft dysfunction after liver transplantation[J]. Dig Dis, 2022, 40(6): 766-776. DOI: 10.1159/000522052.
[35]	MARTINS PN, BERENDSEN TA, YEH H, et al. Oxygenated UW solution decreases ATP decay and improves survival after transplantation of DCD liver grafts[J]. Transplantation, 2019, 103(2): 363-370. DOI: 10.1097/TP.0000000000002530.
[36]	VON HORN C, MINOR T. Transient hyperthermia during oxygenated rewarming of isolated rat livers[J]. Transpl Int, 2020, 33(3): 272-278. DOI: 10.1111/tri.13542.
[37]	MINOR T, VON HORN C, ZLATEV H, et al. Controlled oxygenated rewarming as novel end-ischemic therapy for cold stored liver grafts. a randomized controlled trial[J]. Clin Transl Sci, 2022, 15(12): 2918-2927. DOI: 10.1111/cts.13409.
[38]	BOTEA F, NĂSTASE G, HERLEA V, et al. An exploratory study on isochoric supercooling preservation of the pig liver[J]. Biochem Biophys Rep, 2023, 34: 101485. DOI: 10.1016/j.bbrep.2023.101485.
[39]	BRUINSMA BG, BERENDSEN TA, IZAMIS ML, et al. Supercooling preservation and transplantation of the rat liver[J]. Nat Protoc, 2015, 10(3): 484-494. DOI: 10.1038/nprot.2015.011.